An ongoing dialogue on HIV/AIDS, infectious diseases,
November 5th, 2011
A Mysteriosis about Listeriosis
For obvious reasons, listeriosis has been much in the news recently. The latest information from CDC on the Colorado cantaloupe outbreak cites 139 cases and 29 deaths.
The recent outbreak aside, however, actual cases of listeriosis are pretty rare. We easily could go months in our hospital without seeing a single case, and we have the largest obstetrical service in New England.
Which brings me to the mystery part: Why is medical student knowledge about listeria so high?
I meet with the medical students to review basics of antibiotics at the beginning of every rotation. Depending on the time of year and the number of prior clinical rotations they’ve done, they have variable amounts of ID knowledge before they get here.
But all of them know about listeria. And they know a lot about it.
- Causative organism? (Listeria monocytogenes — check)
- Dietary risk factors? (deli meats, soft cheeses, now cantaloupes — check)
- Population at risk? (pregnant women, transplant patients, and the elderly — check)
- Clinical manifestations? (meningitis, sepsis, gastroenteritis — check)
- Antibiotic of choice? (ampicillin — check)
They seem to know way more about listeria than they do about far more common infections, such as Strep pneumoniae or Epstein-Barr virus.
It’s the oddest thing. Any proposed explanations for this remarkable expertise would be most welcome.
Categories: Health Care, Infectious Diseases, Patient Care
Tags: cantaloupes, Listeria monocytogenes, listeriosis
You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.
6 Responses to “A Mysteriosis about Listeriosis”

Paul E. Sax, MD
Associate Editor
NEJM Clinician
Biography | Disclosures & Summaries
Learn more about HIV and ID Observations.
Search this Blog
Follow HIV and ID Observations Posts via Email
Archives
Most Popular Posts
Sorry. No data so far.
-
From the Blog — Most Recent Articles
- Farewell to This Blog — and Hello to NEJM Voices March 2, 2026
- Some Ruminations on CROI — Still the Best HIV Meeting February 26, 2026
- Two Things Can Be True: The FDA Process Was Inconsistent, and the mRNA Vaccine Data Were Disappointing February 17, 2026
- Sometimes You Just Need to Get Input from a Real Human Being February 12, 2026
- Mystifying Abbreviations — Infectious Diseases Edition February 4, 2026
FROM NEJM — Recent Infectious Disease Articles- Clinical Characteristics of Patients Infected with Bundibugyo Virus, DRC 2026 August 6, 2026Bundibugyo virus, a filovirus, is currently spreading in the Democratic Republic of Congo. This report presents early data on symptoms and illness severity as well as diagnostic challenges.
- Ebola at 50 — Lessons for Outbreak Response and Preparedness August 6, 2026An accurate history of Ebola begins with partnerships, including those between responders and the populations they serve. One of its key lessons is that equity must be integral to outbreak preparedness.
- Cross-Reactive Bundibugyo Antibody Responses after Receipt of Licensed Ebola Vaccines August 6, 2026The Bundibugyo virus outbreak in the DRC and Uganda has focused concern on potential countermeasures. Investigators assessed cross-reactive immune responses in serum obtained during previous Ebola vaccine trials.
- The Inequality–Pandemic Cycle — Rethinking Preparedness August 6, 2026Increasing pandemic frequency and increasing economic inequality are creating a self-reinforcing cycle. What’s needed is therefore a new, inequality-informed approach to pandemic preparedness.
- The Social Contract of Bundibugyo Ebola Isolation August 6, 2026The lack of vaccines and disease-specific therapeutics for Bundibugyo Ebola has dramatically affected the community’s perception of Ebola treatment centers. In this context, trust becomes critical.
- Clinical Characteristics of Patients Infected with Bundibugyo Virus, DRC 2026 August 6, 2026
-
Tag Cloud
- Abacavir AIDS antibiotics antiretroviral therapy ART atazanavir baseball Brush with Greatness CDC C diff COVID-19 CROI darunavir dolutegravir elvitegravir etravirine FDA HCV hepatitis C HIV HIV cure HIV testing ID fellowship ID Learning Unit Infectious Diseases influenza Link-o-Rama lyme disease medical education MRSA PEP PrEP prevention primary care raltegravir Really Rapid Review resistance Retrovirus Conference rilpivirine sofosbuvir TDF/FTC tenofovir Thanksgiving vaccines zoster

For starters, look back to the board exams of the last two decades. There has been a Listeria question on every board exam I’ve ever taken. It’s also been in every board review book I’ve seen (obviously with good reason). If nothing else, we’ve taught our med students to be good test takers.
Perhaps we should also look at the knowledge of the average attending physician. Feel comfortable discussing Listeria on rounds? Well, its been part of pimping lore for a generation….so, Check. Feel comfortable discussing the epidemiology, manifestations, and interpretation of the test of choice for EBV……or the impact on S. pneumo sensitivity patterns on the treatment of meningitis?……Hmm, maybe not so much. That’s when I get a sidebar consult from said attending. Bottom line, we can’t teach what we don’t know. [And to be fair, there’s a wide swath of non-ID subjects I avoid during rounds….]
The same reason that everyone remembers scorpions cause pancreatitis but doesn’t remember drugs. Everyone loves a fascinoma.
I guess it’s because:
– many medschool teachers fail to balance topics by their clinical relevance.
– so do medical textbooks.
– so do, of course, popular media/mass media.
– and a combination of these: it might be more fascinating to go through 500 words of listeriosis – which has been on the news – than go through 50 pages of stroke.
regards,
a.
Jc is exactly right. People dont ask us the easy or common questions often, but you get points for pulling zebras out of your hat. I just took step 1, and I can go on at length about Charcot Marie tooth disease. Please don’t ask me to handle hypertension; I haven’t had my family medicine rotation yet.
Dear UNC MS3 (and others),
Thanks for the MS perspective. Makes sense.
Love that image!
Paul
It is nice to know that pulling zebras out of hats is appreciated more than knowing how to treat hypertension & Strep pneumoniae by medical schools all over the world!